Parameters | Present study | Italy study [17] | |||
---|---|---|---|---|---|
Mean | Median | Interquartile range | Reference ranges a) | Reference ranges a) | |
CD4+T subpopulations (%) | |||||
Th1 | 16.97 | 16.39 | 13.49 | 0.43–39.62 | 6.66–8.01 |
Th2 | 1.35 | 1.19 | 0.97 | 0.27–3.57 | 4.86–5.98 |
Th17 | 1.14 | 1.07 | 0.77 | 0.22–2.62 | 9.50–11.47 |
Treg | 4.80 | 4.74 | 2.17 | 2.17–7.94 | 0.59–0.79 |
Th1:Th2 | 16.96 | 13.40 | 15.14 | 0.59–52.37 | 1.33–1.54 |
Th17:Treg | 0.26 | 0.21 | 0.20 | 0.04–0.76 | 0.06–0.11b) |
CD4+T subpopulations (cells/μl) | |||||
Th1 | 116.87 | 105.77 | 103.75 | 2.64–276.21 | 144.20–171.40 |
Th2 | 9.32 | 8.25 | 7.42 | 1.80–27.14 | 106.40–129.90 |
Th17 | 7.75 | 7.02 | 5.98 | 1.10–19.54 | 201.30–242.00 |
Treg | 32.73 | 30.58 | 18.82 | 13.47–64.58 | 12.79–17.41 |